115450.KQ
HLB Therapeutics Co.,Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 2,560.00
−2.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.49x
- Price / sales
- 3.32x
- Price / cash flow
- -183.18x
Enterprise value
- Enterprise value
- KRW 267.2B
- EV / sales
- 4.14x
- EV / EBITDA
- -37.66x
- EV / EBIT
- -29.91x
- Market cap
- KRW 214.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026